MX2007013866A - Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de uso de los mismos. - Google Patents

Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de uso de los mismos.

Info

Publication number
MX2007013866A
MX2007013866A MX2007013866A MX2007013866A MX2007013866A MX 2007013866 A MX2007013866 A MX 2007013866A MX 2007013866 A MX2007013866 A MX 2007013866A MX 2007013866 A MX2007013866 A MX 2007013866A MX 2007013866 A MX2007013866 A MX 2007013866A
Authority
MX
Mexico
Prior art keywords
methods
pharmaceutical compositions
casein
derived peptides
casein derived
Prior art date
Application number
MX2007013866A
Other languages
English (en)
Inventor
Jose Mario Iscovich
Nissim Silanikove
Javier Iscovich
Original Assignee
Mileutis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mileutis Ltd filed Critical Mileutis Ltd
Publication of MX2007013866A publication Critical patent/MX2007013866A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invencion se refiere a peptidos derivados de caseina y su utilizacion en el manejo de animales en lactancia, en particular a metodos para disminuir la duracion del periodo seco de ganado en lactancia, para incrementar su rendimiento lechero y la higiene de la leche despues de la paricion y para mejorar el bienestar del ganado; la presente invencion se refiere ademas a composiciones farmaceuticas que comprenden peptidos derivados de caseina en la forma de una solucion esteril clara, tales composiciones son claras y sustancialmente libres de micelas.
MX2007013866A 2005-05-02 2006-05-02 Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de uso de los mismos. MX2007013866A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67629205P 2005-05-02 2005-05-02
US68869705P 2005-06-09 2005-06-09
PCT/IL2006/000524 WO2006117784A2 (en) 2005-05-02 2006-05-02 Pharmaceutical compositions comprising casein derived peptides and methods of use thereof

Publications (1)

Publication Number Publication Date
MX2007013866A true MX2007013866A (es) 2008-04-07

Family

ID=37308387

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007013866A MX2007013866A (es) 2005-05-02 2006-05-02 Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de uso de los mismos.

Country Status (18)

Country Link
US (2) US7968513B2 (es)
EP (1) EP1890720B1 (es)
JP (1) JP5247429B2 (es)
KR (2) KR20130122979A (es)
CN (1) CN106421749A (es)
AR (1) AR059462A1 (es)
AU (1) AU2006242842B2 (es)
BR (1) BRPI0611301A2 (es)
CA (1) CA2607155C (es)
CL (1) CL2011000039A1 (es)
EA (1) EA016039B1 (es)
ES (1) ES2400511T3 (es)
IN (1) IN2014DN10391A (es)
MX (1) MX2007013866A (es)
NZ (1) NZ563936A (es)
PL (1) PL1890720T3 (es)
UY (1) UY29515A1 (es)
WO (1) WO2006117784A2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7968513B2 (en) * 2005-05-02 2011-06-28 Mileutis Ltd. Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
CN102124109B (zh) * 2008-06-30 2013-10-16 Cho-A制药有限公司 猪α-S1-酪蛋白基因，其启动子及其用途
US8133916B1 (en) 2009-03-10 2012-03-13 Amelgo, LLC Control of milk production and mammary involution
US20110017323A1 (en) * 2009-07-22 2011-01-27 Ewa Herbst Method and apparatus for inline testing
AU2011243967B2 (en) * 2010-04-21 2015-08-20 Mileutis Ltd. Casein peptide for use in the treatment of uterine infections
FR2971423B1 (fr) * 2011-02-15 2014-01-10 Ceva Sante Animale Composition veterinaire antiprolactinique destinee aux ruminants
ES2759980T3 (es) 2012-03-19 2020-05-12 Mileutis Ltd Péptidos para el manejo de la lactación
EP2810695A1 (en) * 2013-06-06 2014-12-10 Ceva Sante Animale Compositions and Method for controlling infections in non-human mammals using acute phase proteins
NZ753824A (en) * 2016-11-09 2022-08-26 Charles Sturt Univ Livestock supplement and use thereof
KR20190095364A (ko) * 2016-12-13 2019-08-14 디에스엠 아이피 어셋츠 비.브이. Pufa 염 제제 (i)
CN108017709B (zh) * 2017-12-12 2020-04-10 浙江辉肽生命健康科技有限公司 一种生物活性多肽kepmigvnqela及其制备方法和应用
CA3172390A1 (en) * 2020-02-19 2021-08-26 Perfect Day, Inc. Hypoallergenic recombinant milk proteins and compositions comprising the same
WO2024105668A1 (en) * 2022-11-17 2024-05-23 Mileutis Ltd. Compositions and methods for modulating mammary disorders and conditions

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3764670A (en) * 1970-10-28 1973-10-09 Ministry Of Agriculture Polypeptidic anti-biotic substances derived from casein
FR2474829B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications
US5405756A (en) * 1982-03-30 1995-04-11 Meiji Seika Kaisha, Ltd. Transparent acid drink containing acid-soluble casein phosphopeptide
US5015628A (en) * 1986-06-12 1991-05-14 The University Of Melbourne Anticariogenic phosphopeptides
US6448374B1 (en) * 1991-04-19 2002-09-10 The University Of Melbourne Production of phosphopeptides from casein
US5227154A (en) * 1991-08-22 1993-07-13 The University Of Melbourne Phosphopeptides for the treatment of dental calculus
KR0140248B1 (ko) * 1995-03-23 1998-06-15 한상기 신규한 카제인 포스포펩티드, 그것을 포함하는 카제인 및 그 제조방법
AUPO566297A0 (en) * 1997-03-13 1997-04-10 University Of Melbourne, The Calcium phosphopeptide complexes
AUPP494798A0 (en) * 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
NZ517249A (en) 1999-08-24 2004-09-24 Meiji Seika Kaisha Growth promoting and imunpotentiator compositions for mammals using a milk casein phosphopeptide
US6391849B1 (en) * 1999-11-19 2002-05-21 Agricultural Research Organization, The Volcani Center Method and pharmaceutical composition for disrupting lactation in a mammary gland and for treating and preventing mastitis
IL134830A0 (en) * 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
US7666996B2 (en) * 2000-03-01 2010-02-23 Peptera Pharmaceuticals Ltd Casein derived peptides and uses thereof
CA2439236A1 (en) * 2001-03-09 2002-09-19 Meiji Seika Kaisha, Ltd. Immuno-enhancing agent
JP2008509073A (ja) 2004-03-01 2008-03-27 ペプテラ ファーマスーティカルズ エルティーディー． カゼイン由来ペプチドおよびその治療的使用
US7968513B2 (en) * 2005-05-02 2011-06-28 Mileutis Ltd. Pharmaceutical compositions comprising casein derived peptides and methods of use thereof

Also Published As

Publication number Publication date
IN2014DN10391A (es) 2015-08-14
US20110212886A1 (en) 2011-09-01
US8338363B2 (en) 2012-12-25
CN106421749A (zh) 2017-02-22
WO2006117784A2 (en) 2006-11-09
US20090069218A1 (en) 2009-03-12
WO2006117784A3 (en) 2009-05-22
JP2008540399A (ja) 2008-11-20
EP1890720B1 (en) 2013-01-09
CA2607155C (en) 2016-09-13
AU2006242842B2 (en) 2011-12-08
UY29515A1 (es) 2007-11-30
EP1890720A2 (en) 2008-02-27
EP1890720A4 (en) 2010-05-26
NZ563936A (en) 2010-03-26
AR059462A1 (es) 2008-04-09
KR20130122979A (ko) 2013-11-11
EA016039B1 (ru) 2012-01-30
JP5247429B2 (ja) 2013-07-24
PL1890720T3 (pl) 2013-06-28
EA200702401A1 (ru) 2008-08-29
KR20080012933A (ko) 2008-02-12
AU2006242842A1 (en) 2006-11-09
ES2400511T3 (es) 2013-04-10
KR101340676B1 (ko) 2013-12-18
BRPI0611301A2 (pt) 2010-08-31
CA2607155A1 (en) 2006-11-09
US7968513B2 (en) 2011-06-28
CL2011000039A1 (es) 2011-06-10

Similar Documents

Publication Publication Date Title
MX2007013866A (es) Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de uso de los mismos.
CN102550481A (zh) 白山羊羔羊的饲养方法
EP2689783A3 (en) Growth control of oral and superficial microorganisms using gallium compounds
WO2007118963A3 (fr) Composes derives de n-(phenethyl)benzamide substitues, preparation et utilisations
MX340751B (es) Composiciones de alimento para animales de acido abscisico.
FR3056107B1 (fr) Utilisations de pidolate de calcium et/ou de magnesium.
Kumar et al. Existing calf rearing and milking management practices followed by dairy farmers in Uttarakhand
ATE476104T1 (de) Verwendung von 25-hydroxy-vitamin d3 zur verbesserung der vitalität von tieren
RU2013153088A (ru) Композиции, усиливающие вкусовую привлекательность
EA201270779A1 (ru) Новый вид корма для жвачных животных
EA201270220A1 (ru) Молочная композиция, ее применение и продукты на ее основе, смесь для кормления млекопитающих и способ получения такой молочной композиции
PL2219437T5 (pl) Urządzenie do przetrzymywania zwierząt mlecznych
WO2006132665A3 (en) Biocides
RU2009101018A (ru) Индукция толерантности к белкам яиц
RU2008124216A (ru) Способ лечения и профилактики фасциолеза коров
WO2011012240A3 (de) Lipopeptide zur therapie und prophylaxe allergischer erkrankungen
MY169478A (en) Nutritional composition for infants delivered via caesarean section
WO2020176055A3 (en) Measurement method of body composition in ruminant class animals
NZ590609A (en) The use of sandalwood extracts and analogues as animal food additives
NO20070661L (no) Anvendelsen av medisinske planter og ekstrakter derav for dyrs velvaere i veterinaer medisin og zooteknikk
RU2006114596A (ru) Кормовая добавка для поросят-гипотрофиков с использованием стевии
Sarma et al. Trans vaginal correction of dystocia due to fetal arthrogryposis in a Holstein Friesian cow
WO2002061066A8 (en) Method for producing an enzyme from a novel source
EP1743642A8 (en) Use of substituted pyrazoline compounds and their derivatives for the treatment of cannabinoid system-associated diseases
NIŻNIKOWSKI et al. Level of milk performance of sheep and goat suckled by their offspring bred under the conditions of alternative production systems

Legal Events

Date Code Title Description
FG Grant or registration